🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Utah Medical Products, Inc.

UTMD Healthcare
$67.14 +$2.96 (4.61%)
Market Cap: $213.69 M
Gurus Holding
3
Popularity Rank
#3145
% of Shares Held
8.90%
Net Activity (Q1 2026)
-$1.84 M

Guru Ownership Trend

Guru Analysis for Utah Medical Products, Inc. (UTMD)

Utah Medical Products, Inc. (UTMD), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q1 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $19.04 M.

Top institutional holders include Renaissance Technologies (RenTech) and HOTCHKIS & WILEY.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $1.84 M net outflow during the quarter.

On the selling side, HOTCHKIS & WILEY reduced exposure by 18.2%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q1 2026)

+$0
Total Buy Value
New Buys 0
Additions 0
-$1.84 M
Total Sell Value
Reductions 3
Sold Out 0

Guru Consensus (Q1 2026)

Based on recent activity
Net Sellers
3
Net Buyers
0

FAQs for Utah Medical Products, Inc. (UTMD)

Major holders include Renaissance Technologies (RenTech) ($11.41 M), HOTCHKIS & WILEY ($5.53 M), Cliff Asness ($636,709). According to the latest reported data, 3 tracked investment managers collectively hold approximately 283,516 shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $1.84 M, with 0 managers increasing positions and 3 managers reducing holdings.

During the most recent reporting period, 3 managers trimmed their positions, while 0 fully exited UTMD. The total reported sell value was $1.84 M.

No tracked managers opened new positions or increased their holdings in UTMD during the most recent reporting period.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.02% Reduce -4.9% 184,114 $11.41 M Q1 2026
0.02% Reduce -18.2% 89,131 $5.53 M Q1 2026
0.00% Reduce -3.6% 10,271 $636,709 Q1 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form